Their first bid for special access, which came 468 days after the deadline of November 17 2023, was rejected at the end of ...
SAN FRANCISCO, March 05, 2025 (GLOBE NEWSWIRE) -- Grove AI, a company advancing the next generation of clinical trials with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results